Clinical Trials Directory

Trials / Completed

CompletedNCT04097210

Decision-making - the Benefit of Bedside CRP Within Ambulance Care

When Triage is Insufficient - the Benefit of Bedside CRP Within Ambulance Care

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
16 Years – 104 Years
Healthy volunteers

Summary

Patients with degreased (DGC) for ambiguous reasons receive low triage priority. Their death risk is triple. Tools are needed to identify the critically ill patients from this group. The triage used today is not effective. The bedside point-of-care measurements are CRP, lactate acid and suPAR (Soluble Urokinase Plasminogen Activator Receptor). Elevated values associate with the probability of critical illness and predict a risk of death.

Detailed description

Purpose: To improve identification and proper prioritization of patients with non-specific symptoms prehospitally, we intend to investigate whether Q-CRP, a rapid test for CRP, correlates with time-critical states in the above-mentioned patient group alone or together with CRP, lactate and suPAR. The primary endpoint is need for hospital care. Material: Patients over 18 years who exhibit non-specific symptoms and transported to the emergency room. Method: In patients with unspecified conditions, defined according to the inclusion template, a venous blood sample was taken prehospitally at the scene by the EMS. Analysis: Significance tests and regression analyzes with 95% CI were used. The diagnostic accuracy of Q-CRP, lactate, suPAR and combinations thereof were compared with optimal boundary values.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPOC

Timeline

Start date
2016-01-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2019-09-20
Last updated
2022-01-31

Source: ClinicalTrials.gov record NCT04097210. Inclusion in this directory is not an endorsement.